(1α,3β,5Z,7E,22E,24ξ)-9,10-Secoergosta-5,7,10(19),22-tetraene-1,3,24-triol-d3

(1α,3β,5Z,7E,22E,24ξ)-9,10-Secoergosta-5,7,10(19),22-tetraene-1,3,24-triol-d3 Suppliers list
Company Name: Chemsky (shanghai) International Co.,Ltd  
Tel: 021-50135380
Email: shchemsky@sina.com
Products Intro: Product Name:1α,24-Dihydroxy VitaMin D2-d3;(1R,3S,4Z)-4-Methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E)-4-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol-d3; 1,24-DihydroxyvitaMin D2-d3; 1α,24-DihydroxyvitaMin D2-d3; (1α,3β,5Z,7E,22E,24ξ)-9,10-Secoergosta-5,7,10(19),22-tetraene-1,3,24-triol-d3
Purity:98+% Package:1Mg;5Mg;10Mg;50Mg;100Mg;500Mg
Company Name: Toronto Research Chemicals  
Tel: +1 (416) 665-9696
Email: info@trc-canada.com
Products Intro: Package:6250USD/5mg;7750USD/10mg
(1α,3β,5Z,7E,22E,24ξ)-9,10-Secoergosta-5,7,10(19),22-tetraene-1,3,24-triol-d3 Basic information
Product Name:(1α,3β,5Z,7E,22E,24ξ)-9,10-Secoergosta-5,7,10(19),22-tetraene-1,3,24-triol-d3
Synonyms:(1R,3S,4Z)-4-Methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E)-4-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol-d3;(1α,3β,5Z,7E,22E,24ξ)-9,10-Secoergosta-5,7,10(19),22-tetraene-1,3,24-triol-d3;1,24-DihydroxyvitaMin D2-d3;1α,24-Dihydroxy VitaMin D2-d3;1α,24-DihydroxyvitaMin D2-d3
CAS:
MF:C28H44O3
MW:428.64716
EINECS:
Product Categories:
Mol File:Mol File
(1α,3β,5Z,7E,22E,24ξ)-9,10-Secoergosta-5,7,10(19),22-tetraene-1,3,24-triol-d3 Structure
(1α,3β,5Z,7E,22E,24ξ)-9,10-Secoergosta-5,7,10(19),22-tetraene-1,3,24-triol-d3 Chemical Properties
Safety Information
MSDS Information
(1α,3β,5Z,7E,22E,24ξ)-9,10-Secoergosta-5,7,10(19),22-tetraene-1,3,24-triol-d3 Usage And Synthesis
UsesLabelled analogue of 1α,24-Dihydroxyvitamin D2, a naturally occurring metabolite of vitamin D2 (V676040) with low calcemic activity and potent antiproliferative activity. 1α,24-Dihydroxyvitamin D2 is also a metabolite of 1α-Hydroxyvitamin D2 (H995800), a prodrug in development as a treatment for secondary hyperparathyroidism occurring in end stage renal disease.
(1α,3β,5Z,7E,22E,24ξ)-9,10-Secoergosta-5,7,10(19),22-tetraene-1,3,24-triol-d3 Preparation Products And Raw materials
Tag:(1α,3β,5Z,7E,22E,24ξ)-9,10-Secoergosta-5,7,10(19),22-tetraene-1,3,24-triol-d3 Related Product Information